Logo
Sunekos 200

Sunekos 200

Sunekos

Aesthetic / Skin‑booster Injectable
  • Class III CE‑marked medical device as stated by some distributors. :contentReference[oaicite:3]{index=3}
Dermal biostimulator (non\u2011crosslinked HA + amino acids)

Description

Sunekos 200 is an injectable dermal biostimulator combining low molecular weight hyaluronic acid and a patented blend of six amino acids (HY6AA). It is designed to stimulate extracellular matrix (ECM) regeneration by promoting the natural production of collagen and elastin by fibroblasts. The treatment aims to improve skin quality, elasticity, hydration, reduce fine lines, prevent early signs of ageing and restore dermal homeostasis.

Bnefits

  • Stimulates collagen and elastin production via ECM regeneration
  • Improves skin elasticity and firmness
  • Enhances skin hydration (superficial and deep layers)
  • Reduces appearance of fine lines and early wrinkles
  • Improves skin texture, tone and overall skin quality
  • Suitable for subtle rejuvenation without volumizing filler effect
  • Can be applied to face, neck, décolleté, hands and other body areas

Indications

  • Mild to moderate skin laxity
  • Early signs of skin ageing (fine lines, superficial wrinkles)
  • Loss of skin elasticity and firmness
  • Dehydrated or dull skin
  • Skin needing revitalisation and improved dermal quality
  • Areas: face, neck, décolleté, hands, arms, inner thighs, knees (depending on clinic protocol)

Composition

  • Low‑molecular-weight hyaluronic acid (HA)
  • Amino acids: Glycine, L‑Proline, L‑Lysine, L‑Alanine, L‑Valine, L‑Leucine (HY6AA complex)

Formulation

  • Injectable two‑component system: HA vial and amino acid vial (to be reconstituted prior to injection)
  • Non‑crosslinked HA + amino‑acid blend designed for intradermal / mid‑dermal injection by professionals

Packaging

  • Box containing 2 vials of 3 ml HA + 2 vials of amino acids (lyophilised powder, 100 mg each)
  • Intended for several treatment sessions (e.g. up to two treatments per pack depending on protocol)

Usage

  • To be administered only by licensed medical professionals or trained aesthetic practitioners.
  • Inject into middle layers of the dermis using a fine needle (27‑30 G, 12–13 mm length) or as per protocol.
  • Inject 0.1 ml per point, ~1.5 cm apart, following lymphatic drainage direction; after injection gently massage area in direction of lymph flow.
  • Typical protocol: 3–4 sessions spaced 7–10 days apart (depends on skin condition and practitioner assessment).
  • Maintenance treatments may be considered every 4–6 months depending on patient’s skin response.

Contraindications

  • Known hypersensitivity to any component of the product (HA or amino acids)
  • Active skin inflammation or irritation at the treatment site
  • Skin conditions in the area to be treated (inflammation, infection)
  • Patients with clotting disorders or coagulation tendency (as per some distributor contraindications) :contentReference[oaicite:1]{index=1}

Adverse Effects

  • Possible injection‑site reactions: redness, swelling, bruising, mild discomfort (common to injectable treatments)
  • Risk of allergic reaction in individuals hypersensitive to components
  • As with all injectables: risk of infection if procedure not performed under aseptic conditions; potential for uneven texture or overcorrection if improperly administered

Storage Conditions

  • Store at 2°C–25°C (as per distributor recommendations), protect from light and frost; use immediately after reconstitution. :contentReference[oaicite:2]{index=2}

Duration

Series of 3\u20134 sessions over ~3\u20134 weeks; maintenance every 4\u20136 months

Onset

Some improvement often visible after first session; progressive effects over weeks (manufacturer notes visible results after first session and lasting up to 6 months) :contentReference[oaicite:0]{index=0}

Browse more Aesthetic / Skin\u2011booster Injectable

Top Treatments

Top Cities in the UK